Japan's university hospitals face a decisive reform phase driven by demographic aging, fiscal constraints, and intensifying innovation cycles. While effective universityindustry collaboration (UIC) has become essential, partnerships often face challenges because companies prioritize rapid implementation, whereas universities emphasize scientific rigor and public accountability. In 2025, Japan's Ministry of Health, Labour and Welfare (MHLW) required all advanced treatment hospitals to establish academic research organizations (AROs) as part of basic institutional standards, integrating research governance with collaborative capability. Drawing on national policy and practical experience of Chiba University Hospital, this paper examines the rationale, governance, and implications of the ARO mandate. Institutionalizing AROs reframes university hospitals as engines of both scientific credibility and socio-economic innovation.
Keywords: governance and trust; scientific credibility; socio-economic innovation; translational research.
2026, National Center for Global Health and Medicine.